Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France

THERAPIE · Published 2026-04-01 · DOI 10.1016/j.therap.2026.04.001

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.therap.2026.04.001

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Acute pancreatitis followed by leukocytoclastic vasculitis induced by tirzepatide: a first case report with this new medication* · THERAPIE · 2026 · Same journal
Céphalées persistantes secondaires à une injection de dalbavancine : à propos d’un cas · THERAPIE · 2026 · Same journal
Comment discriminer les médicaments d’ASMR V : quelles implications et quel parcours d’accès ? · THERAPIE · 2025 · Same journal
How can the level of health product education (literacy) be raised among the general public? · THERAPIE · 2025 · Same journal
Descriptive study of the effects of treprostinil and/or epoprostenol in newborn infants with inhaled NO refractory persistent pulmonary hypertension of the newborn (PPHN) · THERAPIE · 2026 · Same journal
L’automédication et ses déterminants parmi les militaires français en mission sur les bâtiments de surface de la Marine nationale : une étude descriptive · THERAPIE · 2026 · Same journal
Angioedema reported with tissue plasminogen activators: A need to communicate on bradykinin- and histamine-mediated mechanisms · THERAPIE · 2026 · Same journal
Antipsychotics switching, a specific risk of thromboembolic events? A case report · THERAPIE · 2026 · Same journal
Artificial intelligence for precision medicine · THERAPIE · 2025 · Same journal
Pharmaco-metabolomics and metabolomics: A new tool in precision medicine? · THERAPIE · 2025 · Same journal